Results 21 to 30 of about 16,082 (221)

Red Cell Shearing Between Transcatheter Heart Valves? Acute Hemolysis after Emergency TAVR-in-TAVR

open access: yes, 2020
Red Cell Shearing Between Transcatheter Heart Valves?
William W. O’Neill (8610585)   +5 more
core   +1 more source

TAVR for Bicuspid Aortic Valve

open access: yes, 2023
Bicuspid aortic valve (BAV) is the most common congenital heart valve abnormality. Different BAV phenotypes determine procedural and clinical success with transcatheter aortic valve replacement (TAVR).
Van Mieghem, Nicolas M., Adrichem, Rik
core   +1 more source

Smoking and TAVR

open access: yesJournal of the American Heart Association, 2019
See Article Qintar et al
J. James Edelman, Vinod H. Thourani
openaire   +3 more sources

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry

open access: yesOpen Heart, 2020
Objectives Patients’ backgrounds and clinical outcomes in urgent/emergent/salvage transcatheter aortic valve replacement (Em-TAVR) remain unclear. We investigated patient characteristics and the mortality in Em-TAVR and the predictors for the need for Em-
Yusuke Watanabe   +15 more
doaj   +1 more source

Direct aortic route versus transaxillary route for transcatheter aortic valve replacement: a systematic review and meta-analysis [PDF]

open access: yesPeerJ, 2020
Background The transfemoral route is contraindicated in nearly 10% of transcatheter aortic valve replacement (TAVR) candidates because of unsuitable iliofemoral vessels. Transaxillary (TAx) and direct aortic (DAo) routes are the principal nonfemoral TAVR
Hsiu-An Lee   +9 more
doaj   +2 more sources

Transcatheter aortic valve replacement- management of patients with significant coronary artery disease undergoing aortic valve interventions: surgical compared to catheter-based approaches in hybrid procedures

open access: yesBMC Cardiovascular Disorders, 2019
Background Coronary artery disease (CAD) is associated with poorer outcomes after aortic valve replacement (AVR). For high-risk patients with complex CAD, combined transcatheter aortic valve replacement (TAVR) plus off-pump/minimally-invasive coronary ...
Hardy Baumbach   +9 more
doaj   +1 more source

Comparison of Outcomes Following Transcatheter Aortic Valve Replacement Requiring Peripheral Vascular Intervention or Alternative Access

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Peripheral vascular intervention (PVI) is occasionally required to facilitate delivery system insertion or to treat vascular complications during transfemoral transcatheter aortic valve replacement (TF‐TAVR).
Toshiaki Isogai   +9 more
doaj   +1 more source

Tips and Tricks in Transaortic TAVR

open access: yesBrazilian Journal of Cardiovascular Surgery, 2022
Transfemoral transcatheter aortic valve replacement (TAVR) is currently the standard catheter-based treatment of severe aortic stenosis patients. Being the transfemoral route not feasible, other access sites could be chosen. Transaortic TAVR via either a J mini-sternotomy or a right anterolateral mini-thoracotomy is a good option for patients having ...
Gennari M   +4 more
openaire   +6 more sources

Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non‐TAVR Centers

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Transcatheter aortic valve replacement (TAVR) has solidified the importance of a heart team and revolutionized patient selection for surgical aortic valve replacement (SAVR).
Godly Jack   +8 more
doaj   +1 more source

New Model for the Assessment of Transcatheter Aortic Valve Replacement Devices in Sheep

open access: yesJournal of Investigative Surgery, 2022
Background Transcatheter aortic valve replacement (TAVR) is an effective therapy in treating high-risk patients suffering from aortic stenosis. Animal models used to evaluate safety and efficacy of TAVR devices prior to clinical use lack a stenotic ...
John P. Carney   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy